Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma

1. De Queiroz Crusoe, E.
2. Maiso, P.
3. Fernandez-Lazaro, D.
4. San-Segundo, L.
5. Garayoa, M.
6. Garcia-Gomez, A.
7. Gutierrez, N.C.
8. Delgado, M.
9. Colado, E.
10. Martin-Sanchez, J.
11. Lee, F.Y.
12. Ocio, E.M.